Harvey Nichols To Sell MGC Derma and Derma Plus Cosmetics
Filed with ASX · · 3 pages · English
Earlier from Argent Biopharma
- Maltese Government Approves Medicinal Cannabis Legislation
- Corporate Update - CEO steps into Managing Director role
- MGC Derma launches Second Derma Plus CBD Product
- Malta Govt Approval for MC Licensed Facility
- $5m Placement at 7.0c Closed Stongly Oversubscribed
Later from Argent Biopharma
- MXC Awarded GMP Certification & Manufacturing Licence
- Harvey Nichols Expands MGC Derma Distribution in the UK
- MXC to Commence Australian Dementia Trial with Notre Dame
- Appendix 4E and Audited 2018 Financial Report
- MXC Signs Major Distribution Agreement for GMP Products
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma